122 related articles for article (PubMed ID: 11590321)
1. Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer.
Kleeff J; Shi X; Bode HP; Hoover K; Shrikhande S; Bryant PJ; Korc M; Büchler MW; Friess H
Pancreas; 2001 Oct; 23(3):259-65. PubMed ID: 11590321
[TBL] [Abstract][Full Text] [Related]
2. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma.
Guo J; Kleeff J; Zhao Y; Li J; Giese T; Esposito I; Büchler MW; Korc M; Friess H
Int J Mol Med; 2006 May; 17(5):761-7. PubMed ID: 16596258
[TBL] [Abstract][Full Text] [Related]
3. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
[TBL] [Abstract][Full Text] [Related]
4. Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma.
Chlenski A; Ketels KV; Tsao MS; Talamonti MS; Anderson MR; Oyasu R; Scarpelli DG
Int J Cancer; 1999 Jul; 82(1):137-44. PubMed ID: 10360833
[TBL] [Abstract][Full Text] [Related]
5. HPAF-II, a cell culture model to study pancreatic epithelial cell structure and function.
Rajasekaran SA; Gopal J; Espineda C; Ryazantsev S; Schneeberger EE; Rajasekaran AK
Pancreas; 2004 Oct; 29(3):e77-83. PubMed ID: 15367897
[TBL] [Abstract][Full Text] [Related]
6. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
7. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
8. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.
Welsch T; Keleg S; Bergmann F; Bauer S; Hinz U; Schmidt J
Pancreas; 2009 Nov; 38(8):968-76. PubMed ID: 19672209
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin.
Youakim A; Ahdieh M
Am J Physiol; 1999 May; 276(5):G1279-88. PubMed ID: 10330020
[TBL] [Abstract][Full Text] [Related]
10. ZO-1 mRNA and protein expression during tight junction assembly in Caco-2 cells.
Anderson JM; Van Itallie CM; Peterson MD; Stevenson BR; Carew EA; Mooseker MS
J Cell Biol; 1989 Sep; 109(3):1047-56. PubMed ID: 2670954
[TBL] [Abstract][Full Text] [Related]
11. Zonula occludens-1 (ZO-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells.
Tan X; Egami H; Ishikawa S; Kurizaki T; Hirota M; Ogawa M
Dig Dis Sci; 2005 Aug; 50(8):1402-9. PubMed ID: 16110828
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis.
Li J; Li Z; Jiang P; Peng M; Zhang X; Chen K; Liu H; Bi H; Liu X; Li X
J Exp Clin Cancer Res; 2018 Jul; 37(1):177. PubMed ID: 30064461
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
14. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.
Grützmann R; Lüttges J; Sipos B; Ammerpohl O; Dobrowolski F; Alldinger I; Kersting S; Ockert D; Koch R; Kalthoff H; Schackert HK; Saeger HD; Klöppel G; Pilarsky C
Br J Cancer; 2004 Mar; 90(5):1053-8. PubMed ID: 14997207
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Indian hedgehog and its receptors patched and smoothened in human chronic pancreatitis.
Kayed H; Kleeff J; Keleg S; Büchler MW; Friess H
J Endocrinol; 2003 Sep; 178(3):467-78. PubMed ID: 12967338
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma.
Cui Y; Li T; Zhang D; Han J
Cancer Invest; 2010 Mar; 28(3):242-7. PubMed ID: 20158339
[TBL] [Abstract][Full Text] [Related]
17. Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis.
Liao Q; Kleeff J; Xiao Y; Guweidhi A; Schambony A; Töpfer-Petersen E; Zimmermann A; Büchler MW; Friess H
Histol Histopathol; 2003 Apr; 18(2):425-33. PubMed ID: 12647793
[TBL] [Abstract][Full Text] [Related]
18. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.
Maruyama H; Kleeff J; Wildi S; Friess H; Büchler MW; Israel MA; Korc M
Am J Pathol; 1999 Sep; 155(3):815-22. PubMed ID: 10487839
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma.
Xie MJ; Motoo Y; Iovanna JL; Su SB; Ohtsubo K; Matsubara F; Sawabu N
Dig Dis Sci; 2003 Mar; 48(3):459-64. PubMed ID: 12757156
[TBL] [Abstract][Full Text] [Related]
20. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
